Inhibiting homologous recombination by targeting RAD51 protein - Le Mans Université Accéder directement au contenu
Article Dans Une Revue Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Année : 2021

Inhibiting homologous recombination by targeting RAD51 protein

Résumé

Homologous recombination (HR) is involved in repairing DNA double-strand breaks (DSB), the most harmful for the cell. Regulating HR is essential for maintaining genomic stability. In many forms of cancer, overactivation of HR increases tumor resistance to DNA-damaging treatments. RAD51, HR's core protein, is very often over- expressed in these cancers and plays a critical role in cancer cell development and survival. Targeting RAD51 directly to reduce its activity and its expression is therefore one strategy to sensitize and overcome resistance cancer cells to existing DNA-damaging therapies which remains the limiting factor for the success of targeted therapy.This review describes the structure and biological roles of RAD51, summarizes the different targeted sites of RAD51 and its inhibitory compounds discovered and described in the last decade.
Fichier principal
Vignette du fichier
S0304419X21000949.pdf (713.16 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03347460 , version 1 (02-08-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

A. Demeyer, H. Benhelli-Mokrani, Benoît Chénais, P. Weigel, F. Fleury. Inhibiting homologous recombination by targeting RAD51 protein. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1876 (2), pp.188597. ⟨10.1016/j.bbcan.2021.188597⟩. ⟨hal-03347460⟩
54 Consultations
34 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More